{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:28:54Z","timestamp":1771356534849,"version":"3.50.1"},"reference-count":75,"publisher":"Colegio Mexicano de Inmunologia Clinica y Alergia, A. C.","issue":"4","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["RAM"],"abstract":"<jats:p>Las enfermedades reum\u00e1ticas autoinmunes son trastornos multisist\u00e9micos que afectan principalmente las articulaciones y los m\u00fasculos; algunos ejemplos de estas afecciones son la artritis reumatoide, el lupus eritematoso sist\u00e9mico y el s\u00edndrome de Sj\u00f6gren. En general, las enfermedades reum\u00e1ticas autoinmunes tienen una alta prevalencia en todo el mundo y son altamente incapacitantes para quienes las padecen. Una de las principales limitaciones en la actualidad para el manejo de estas enfermedades es que su factor desencadenante sigue siendo desconocido en la mayor\u00eda de los casos y el conocimiento de los factores asociados con su exacerbaci\u00f3n es limitado. En esta revisi\u00f3n se explorar\u00e1 la posible relaci\u00f3n de las alergias como desencadenante de enfermedades reum\u00e1ticas autoinmunes. Tambi\u00e9n analizaremos los aspectos b\u00e1sicos y generales de ambas enfermedades y el desarrollo de procesos al\u00e9rgicos y reacciones de hipersensibilidad a los f\u00e1rmacos utilizados en el tratamiento de enfermedades reum\u00e1ticas.<\/jats:p>","DOI":"10.29262\/ram.v68i4.984","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T21:08:00Z","timestamp":1638911280000},"page":"264-275","source":"Crossref","is-referenced-by-count":3,"title":["Enfermedades reum\u00e1ticas y alergias, la dualidad del sistema inmunol\u00f3gico"],"prefix":"10.29262","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4390-8604","authenticated-orcid":false,"given":"Gabriela Athziri","family":"S\u00e1nchez-Zuno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6010-0837","authenticated-orcid":false,"given":"Edith","family":"Oreg\u00f3n-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8004-1811","authenticated-orcid":false,"given":"Jorge","family":"Hern\u00e1ndez-Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0244-6298","authenticated-orcid":false,"given":"Guillermo","family":"Gonz\u00e1lez-Estevez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9042-0839","authenticated-orcid":false,"given":"Rodrigo","family":"Vargas-Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2272-9260","authenticated-orcid":false,"given":"Jos\u00e9 Francisco","family":"Mu\u00f1oz-Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11808","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yebeh.2016.12.019","article-title":"Clinical characteristics, treatments, and outcomes of patients with anti- N -methyl- d -aspartate receptor encephalitis: a systematic review of reported cases","volume":"68","author":"Zhang","year":"2017","unstructured":"Zhang L, Wu M-Q, Hao Z-L, Chiang SMV, et al. Clinical characteristics, treatments, and outcomes of patients with anti- N -methyl- d -aspartate receptor encephalitis: a systematic review of reported cases. Epilepsy Behav. 2017;68:57-65.","journal-title":"Epilepsy Behav"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Dalmau J, Lancaster E, Mart\u00ednez-Hern\u00e1ndez E, Rosenfeld MR. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63-74. DOI: 10.1016\/S1474-4422(10)70253-2","DOI":"10.1016\/S1474-4422(10)70253-2"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391-404. DOI: 10.1016\/S1474-4422(15)00401-9","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7(12):1091-1098. DOI: 10.1016\/S1474-4422(08)70224-2","DOI":"10.1016\/S1474-4422(08)70224-2"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157-165. DOI: 10.1016\/S1474-4422(12)70310-1","DOI":"10.1016\/S1474-4422(12)70310-1"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Maneta E, Garcia G. Psychiatric manifestations of anti-NMDA receptor encephalitis: neurobiological underpinnings and differential diagnostic implications. Psychosomatics. 2014;55(1):37-44. DOI: 10.1016\/j.psym.2013.06.002","DOI":"10.1016\/j.psym.2013.06.002"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018;378(9):840-851. DOI: 10.1056\/NEJMra1708712","DOI":"10.1056\/NEJMra1708712"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005;58(4):594-604. DOI: 10.1002\/ana.20614","DOI":"10.1002\/ana.20614"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Dalmau J, T\u00fcz\u00fcn E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61(1):25-36. DOI: 10.1002\/ana.21050","DOI":"10.1002\/ana.21050"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Eker A, Saka E, Dalmau J, Kurne A, Bilen C, Ertoy D, et al. Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis. J Neurol Neurosurg Psychiatry. 2008;79(9):1082-1083. DOI: 10.1136\/jnnp.2008.147611","DOI":"10.1136\/jnnp.2008.147611"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Guasp M, Dalmau J. Encefalitis por anticuerpos contra el receptor de NMDA. Med Clin. 2018;151(2):71-79. DOI: 10.1016\/j.medcli.2017.10.015","DOI":"10.1016\/j.medcli.2017.10.015"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Granerod J, Ambrose HE, Davies NW, Clewly JP, Walsh AL, Morgan D, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10(12):835-844. DOI: 10.1016\/S1473-3099(10)70222-X. DOI: 10.1016\/S1473-3099(10)70222-X","DOI":"10.1016\/S1473-3099(10)70222-X"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser A, et al. The Frequency of autoimmune N-Methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project. Clin Infect Dis. 2012;54(7):899-904. DOI: 10.1093\/cid\/cir1038","DOI":"10.1093\/cid\/cir1038"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Huang Q, Wu Y, Qin R, Wei X, Ma M. Clinical characteristics and outcomes between children and adults with anti-N-Methyl-d-Aspartate receptor encephalitis. J Neurol. 2016;263(12):2446-2455. DOI: 10.1007\/s00415-016-8282-1","DOI":"10.1007\/s00415-016-8282-1"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Irani SR, Vincent A. NMDA receptor antibody encephalitis. Curr Neurol Neurosci Rep. 2011;11(3):298-304. DOI: 10.1007\/s11910-011-0186-y","DOI":"10.1007\/s11910-011-0186-y"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Dalmau J. NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: the 2016 Cotzias Lecture. Neurology. 2016;87(23):2471-2482. DOI: 10.1212\/WNL.0000000000003414","DOI":"10.1212\/WNL.0000000000003414"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Bortnick A, Allman D. What Is and what should always have been: long-lived plasma cells induced by T cell-independent antigens. J Immunol. 2013;190(12):5913-5918. DOI: 10.4049\/jimmunol.1300161","DOI":"10.4049\/jimmunol.1300161"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Armangue T, Moris G, Cantar\u00edn-Extremera V, Conde CE, Rostasy K, Erro ME, et al. Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology. 2015;85(20):1736-1743. DOI: 10.1212\/WNL.0000000000002125","DOI":"10.1212\/WNL.0000000000002125"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Cull-Candy S, Brickley S, Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol. 2001;11(3):327-335. DOI: 10.1016\/s0959-4388(00)00215-4","DOI":"10.1016\/S0959-4388(00)00215-4"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Corlew R, Brasier DJ, Feldman DE, Philpot BD. Presynaptic NMDA receptors: newly appreciated roles in cortical synaptic function and plasticity. Neuroscientist. 2008;14(6):609-625. DOI: 10.1177\/1073858408322675","DOI":"10.1177\/1073858408322675"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Steffens M, Huppertz H-J, Zentner J, Chauzit E. Unchanged glutamine synthetase activity and increased NMDA receptor density in epileptic human neocortex: implications for the pathophysiology of epilepsy. Neurochem Int. 2005;47(6):379-384. DOI: 10.1016\/j.neuint.2005.06.001","DOI":"10.1016\/j.neuint.2005.06.001"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Olney JW, Newcomer JW, Farber NB. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res. 1999;33(6):523-533. DOI: 10.1016\/S0022-3956(99)00029-1","DOI":"10.1016\/S0022-3956(99)00029-1"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Huang Q, Xie Y, Hu Z, Tang X. Anti-N-methyl-D-aspartate receptor encephalitis: a review of pathogenic mechanisms, treatment, prognosis. Brain Res. 2020;1727:146549. DOI: 10.1016\/j.brainres.2019.146549","DOI":"10.1016\/j.brainres.2019.146549"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Hirohata S, Tanaka K. Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosus. Lupus Sci Med. 2019;13;6(1):e000359. DOI: 10.1136\/lupus-2019-000359","DOI":"10.1136\/lupus-2019-000359"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Arinuma Y. Antibodies and the brain: anti-N-methyl-D-aspartate receptor antibody and the clinical effects in patients with systemic lupus erythematosus. Curr Opin Neurol. 2018;31(3):294-299. DOI: 10.1097\/WCO.0000000000000554","DOI":"10.1097\/WCO.0000000000000554"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51(3):199-214. DOI: 10.1001\/archpsyc.1994.03950030035004","DOI":"10.1001\/archpsyc.1994.03950030035004"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis, autoimmunity, and psychosis. Schizophr Res. 2016;176(1):36-40. DOI: 10.1016\/j.schres.2014.10.007","DOI":"10.1016\/j.schres.2014.10.007"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Moghaddam B, Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 2012;37(1):4-15. DOI: 10.1038\/npp.2011.181","DOI":"10.1038\/npp.2011.181"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Lynch DR, Rattelle A, Dong YN, Roslin K, Gleichman AJ, Panzer JA. Anti-NMDA receptor encephalitis: clinical features and basic mechanisms. Adv Pharmacol. 2018;82:235-260. DOI: 10.1016\/bs.apha.2017.08.005","DOI":"10.1016\/bs.apha.2017.08.005"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Wang R, Lai X, Liu X, Li Y-J, Chen C, Li C, et al. Brain magnetic resonance-imaging findings of anti-N-methyl-d-aspartate receptor encephalitis: a cohort follow-up study in Chinese patients. J Neurol. 2018;265(2):362-369. DOI: 10.1007\/s00415-017-8707-5","DOI":"10.1007\/s00415-017-8707-5"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Catani M, Dell'acqua F, de Schotten MT. A revised limbic system model for memory, emotion and behaviour. Neurosci Biobehav Rev. 2013;37(8):1724-1737. DOI: 10.1016\/j.neubiorev.2013.07.001","DOI":"10.1016\/j.neubiorev.2013.07.001"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Parenti A, Jardri R, Geoffroy PA. How anti-NMDAR encephalitis sheds light on the mechanisms underlying catatonia: the neural excitatory\/inhibitory imbalance model. Psychosomatics. 2016;57(3):336-338. DOI: 10.1016\/j.psym.2016.01.007","DOI":"10.1016\/j.psym.2016.01.007"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Finke C, Kopp UA, Pajkert A, Behrens JR, Leypoldt F, Wuerfel JT, et al. Structural hippocampal damage following anti-N-Methyl-D-aspartate receptor encephalitis. Biol Psychiatry. 2016;79(9):727-734. DOI: 10.1016\/j.biopsych.2015.02.024","DOI":"10.1016\/j.biopsych.2015.02.024"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Dalmau J, Armangu\u00e9 T, Planagum\u00e0 J, Radosevic M, Mannara F, Leypoldt F, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045-1057. DOI: 10.1016\/S1474-4422(19)30244-3","DOI":"10.1016\/S1474-4422(19)30244-3"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Barry H, Hardiman O, Healy DG, Keogan M, Moroney J, Molnar PP, et al. Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis. Br J Psychiatry. 2011;199(06):508-509. DOI: 10.1192\/bjp.bp.111.092197","DOI":"10.1192\/bjp.bp.111.092197"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Chapman MR, Vause HE. Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry. 2011;168(3):245-251. DOI: 10.1176\/appi.ajp.2010.10020181","DOI":"10.1176\/appi.ajp.2010.10020181"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Schieveld JNM, Strik JJMH, van Kraaij S, Nicolai J. Psychiatric manifestations and psychopharmacology of autoimmune encephalitis: a multidisciplinary approach. Handb Clin Neurol. 2019;165:285-307. DOI: 10.1016\/B978-0-444-64012-3.00017-4","DOI":"10.1016\/B978-0-444-64012-3.00017-4"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Gibson LL, Pollak TA, Blackman G, Thornton M, Moran N, David AS. The psychiatric phenotype of anti-NMDA receptor encephalitis. J Neuropsychiatry Clin Neurosci. 2019;31(1):70-79. DOI: 10.1176\/appi.neuropsych.17120343","DOI":"10.1176\/appi.neuropsych.17120343"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Liu C, Zhu J, Zheng X-Y, Ma C, Wang X. Anti-N-Methyl-D-aspartate receptor encephalitis: a severe, potentially reversible autoimmune encephalitis. Mediators Inflamm. 2017;2017:6361479. DOI: 10.1155\/2017\/6361479","DOI":"10.1155\/2017\/6361479"},{"issue":"1","key":"ref39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1192\/pb.bp.113.045518","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment","volume":"39","author":"Barry","year":"2015","unstructured":"Barry H, Byrne S, Barrett E, Murphy KC, Cotter DR. Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment. BJPsych Bull. 2015;39(1):19-23.","journal-title":"BJPsych Bull"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Maat P, de Graaff E, van Beveren NM, Hulsenboom E, Verdijk RM, Koorengevel K, et al. Psychiatric phenomena as initial manifestation of encephalitis by anti\u2010NMDAR antibodies. Acta Neuropsychiatr. 2013;25(3):128-136. DOI: 10.1111\/acn.12013","DOI":"10.1111\/acn.12013"},{"issue":"5","key":"ref41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/acps.12941","article-title":"Refining the psychiatric syndrome of anti-N -methyl- d -aspartate receptor encephalitis","volume":"138","author":"Warren","year":"2018","unstructured":"Warren N, Siskind D, O'Gorman C. Refining the psychiatric syndrome of anti-N -methyl- d -aspartate receptor encephalitis. Acta Psychiatr Scand. 2018;138(5):401-408.","journal-title":"Acta Psychiatr Scand"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Foley SR, Kelly BD, Clarke M, McTigue O, Gervin M, Kamali M, et al. Incidence and clinical correlates of aggression and violence at presentation in patients with first episode psychosis. Schizophr Res. 2005;72(2-3):161-168. DOI: 10.1016\/j.schres.2004.03.010","DOI":"10.1016\/j.schres.2004.03.010"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Compton MT, Fantes F, Wan CR, Johnson S, Walker EF. Abnormal movements in first-episode, nonaffective psychosis: dyskinesias, stereotypies, and catatonic-like signs. Psychiatry Res. 2015;226(1):192-197. DOI: 10.1016\/j.psychres.2014.12.048","DOI":"10.1016\/j.psychres.2014.12.048"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Waters F, Collerton D, Ffytche DH, Jardri R, Pins D, Dudley R, et al. Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease. Schizophr Bull. 2014;40(Suppl 4):S233-S245. DOI: 10.1093\/schbul\/sbu036","DOI":"10.1093\/schbul\/sbu036"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Espinola-Nadurille M, Bustamante-G\u00f3mez P, Ram\u00edrez-Berm\u00fadez J, Bayliss L, Rivas-Alonso V, Flores-Rivera J. Frequency of neuropsychiatric disturbances in anti-NMDA receptor encephalitis. Acta Psychiatr Scand. 2018;138(5):483-485. DOI: 10.1111\/acps.12963","DOI":"10.1111\/acps.12963"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Fink M, Taylor MA. The catatonia syndrome: forgotten but not gone. Arch Gen Psychiatry. 2009;66(11):1173-1177. DOI: 10.1001\/archgenpsychiatry.2009.141","DOI":"10.1001\/archgenpsychiatry.2009.141"},{"issue":"9","key":"ref47","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis","volume":"70","author":"Kayser","year":"2013","unstructured":"Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J. Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis. JAMA Neurol. 2013;70(9):1133.","journal-title":"JAMA Neurol"},{"issue":"1","key":"ref48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4172\/Neuropsychiatry.1000322","article-title":"Psychiatric symptoms and electroencephalograms in anti-NMDAR encephalitis","volume":"8","author":"Kataoka","year":"2018","unstructured":"Kataoka H, Takatani T. Psychiatric symptoms and electroencephalograms in anti-NMDAR encephalitis. Neuropsychiatry. 2018;8(1):38-41.","journal-title":"Neuropsychiatry"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Reid DK, Clardy SL. Anti-NMDA-receptor encephalitis: unusual presentation of an uncommon condition. J Neurol Neurosurg Psychiatry. 2013;84(1):69-70. DOI: 10.1136\/jnnp-2012-302904","DOI":"10.1136\/jnnp-2012-302904"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Liu X, Yan B, Wang R, Li C, Chen C, Zhou D, et al. Seizure outcomes in patients with anti-NMDAR encephalitis: a follow-up study. Epilepsia. 2017;58(12):2104-2111. DOI: 10.1111\/epi.13929","DOI":"10.1111\/epi.13929"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Viaccoz A, Desestret V, Ducray F, Picard G, Cavillon G, Rogemond V, et al. Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology. 2014;82(7):556-563. DOI: 10.1212\/WNL.0000000000000126","DOI":"10.1212\/WNL.0000000000000126"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Kleinig TJ, Thompson PD, Matar W, Duggins A, Kimber TE, Morris JG, et al. The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord. 2008;23(9):1256-1261. DOI: 10.1002\/mds.22073","DOI":"10.1002\/mds.22073"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Mu\u00f1oz-Lopetegi A, Graus F, Dalmau J, Santamaria J. Sleep disorders in autoimmune encephalitis. Lancet Neurol. 2020;19(12):1010-1022. DOI: 10.1016\/S1474-4422(20)30341-0","DOI":"10.1016\/S1474-4422(20)30341-0"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D. Extreme delta brush: A unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. 2012;79(11):1094-1100. DOI: 10.1212\/WNL.0b013e3182698cd8","DOI":"10.1212\/WNL.0b013e3182698cd8"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Freund B, Ritzl EK. A review of EEG in anti-NMDA receptor encephalitis. J Neuroimmunol. 2019;332:64-68. DOI: 10.1016\/j.jneuroim.2019.03.010","DOI":"10.1016\/j.jneuroim.2019.03.010"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Yu Y, Wu Y, Cao X, Li J, Liao X, Wei J, et al. The clinical features and prognosis of anti-NMDAR encephalitis depends on blood brain barrier integrity. Mult Scler Relat Disord. 2021;47:102604. DOI: 10.1016\/j.msard.2020.102604","DOI":"10.1016\/j.msard.2020.102604"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Espinola-Nadurille M, Bautista-G\u00f3mez P, Flores J, Rivas-Alonso V, P\u00e9rez-Esparza R, Sol\u00eds-Vivanco R, et al. Non-inflammatory cerebrospinal fluid delays the diagnosis and start of immunotherapy in anti-NMDAR encephalitis. Arq Neuropsiquiatr. 2018;76(1):2-5. DOI: 10.1590\/0004-282X20170179","DOI":"10.1590\/0004-282x20170179"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Probasco JC, Solnes L, Nalluri A, Cohen J, Jones KM, Zan E, et al. Decreased occipital lobe metabolism by FDG-PET\/CT: An anti-NMDA receptor encephalitis biomarker. Neurol Neuroimmunol Neuroinflamm. 2018;5(1):e413. DOI: 10.1212\/NXI.0000000000000413","DOI":"10.1212\/NXI.0000000000000413"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Lennox BR, Coles AJ, Vincent A. Antibody-mediated encephalitis: a treatable cause of schizophrenia. Br J Psychiatry. 2012;200(2):92-94. DOI: 10.1192\/bjp.bp.111.095042","DOI":"10.1192\/bjp.bp.111.095042"},{"issue":"3","key":"ref60","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","article-title":"Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N -Methyl-D-aspartate glutamate receptor encephalitis","volume":"70","author":"Steiner","year":"2013","unstructured":"Steiner J, Walter M, Glanz W, et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N -Methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry. 2013;70(3):271.","journal-title":"JAMA Psychiatry"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Restrepo-Mart\u00ednez M, Paola-Bautista G, Espinola-Nadurille M, Bayliss L. Banderas rojas para sospechar encefalitis anti-NMDAr en un primer episodio psic\u00f3tico: reporte de dos casos. Rev Colomb Psiquiatr. 2017;48(2):127-130. DOI: 10.1016\/j.rcp.2017.10.002","DOI":"10.1016\/j.rcp.2017.10.002"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez-Valc\u00e1rcel J, Rosenfeld MR, Dalmau J. Differential diagnosis of encephalitis due to anti-NMDA receptor antibodies. Neurologia. 2010;25(7):409-413. Disponible en: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3101880\/","DOI":"10.1016\/S2173-5808(10)70077-8"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Zhang Y, Liu G, Jiang M, Chen W, Su Y. Efficacy of therapeutic plasma exchange in patients with severe refractory anti-NMDA receptor encephalitis. Neurotherapeutics. 2019;16(3):828-837. DOI: 10.1007\/s13311-019-00725-4","DOI":"10.1007\/s13311-019-00725-4"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Kuppuswamy PS, Takala CR, Sola CL. Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions. Gen Hosp Psychiatry. 2014;36(4):388-391. DOI: 10.1016\/j.genhosppsych.2014.02.010","DOI":"10.1016\/j.genhosppsych.2014.02.010"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis in psychiatry. Curr Psychiatry Rev. 2011;7(3):189-193. DOI: 10.2174\/157340011797183184","DOI":"10.2174\/157340011797183184"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Lejuste F, Thomas L, Picard G, Desestret V, Ducray F, Rogemond V, et al. Neuroleptic intolerance in patients with anti-NMDAR encephalitis. Neurol Neuroimmunol Neuroinflamm. 2016;3(5):e280. DOI: 10.1212\/NXI.0000000000000280","DOI":"10.1212\/NXI.0000000000000280"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Fink M. Rediscovering catatonia: the biography of a treatable syndrome. Acta Psychiatr Scand. 2013;127(441):1-47. DOI: 10.1111\/acps.12038","DOI":"10.1111\/acps.12038"},{"issue":"2","key":"ref68","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.brs.2018.11.016","article-title":"Electroconvulsive therapy for anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: a systematic review of cases","volume":"12","author":"Warren","year":"2019","unstructured":"Warren N, Grote V, O'Gorman C, Siskind D. Electroconvulsive therapy for anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: a systematic review of cases. Brain Stimul. 2019;12(2):329-334.","journal-title":"Brain Stimul"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Santoro JD, Filippakis A, Chitnis T. Ketamine use in refractory status epilepticus associated with anti-NMDA receptor antibody encephalitis. Epilepsy Behav Rep. 2019; 23;12:100326. DOI: 10.1016\/j.brs.2018.11.016","DOI":"10.1016\/j.brs.2018.11.016"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Xu X, Lu Q, Huang Y, Fan S, Zhou L, Yuan J, et al. Anti-NMDAR encephalitis: a single-center, longitudinal study in China. Neurol Neuroimmunol Neuroinflamm. 2019;16;7(1):e633. DOI: 10.1212\/NXI.0000000000000633","DOI":"10.1212\/NXI.0000000000000633"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Finke C, Kopp UA, Pr\u00fcss H, Dalmau J, Wandinger KP, Ploner CJ. Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2012;83(2):195-198. DOI: 10.1136\/jnnp-2011-300411","DOI":"10.1136\/jnnp-2011-300411"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"McKeon GL, Robinson GA, Ryan AE, Blum S, Gillis D, Finke C, et al. Cognitive outcomes following anti-N-methyl-D-aspartate receptor encephalitis: a systematic review. J Clin Exp Neuropsychol. 2018;40(3):234-252. DOI: 10.1080\/13803395.2017.1329408","DOI":"10.1080\/13803395.2017.1329408"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCraken L, Leypoldt F, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13(2):167-177. DOI: 10.1016\/S1474-4422(13)70282-5.","DOI":"10.1016\/S1474-4422(13)70282-5"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Wang K, Chen Z, Wu D, Ding Q, Zheng X, Wang J, et al. Early second-line therapy is associated with improved episodic memory in anti-NMDA receptor encephalitis. Ann Clin Transl Neurol. 2019;6(7):1202-1213. DOI: 10.1002\/acn3.50798","DOI":"10.1002\/acn3.50798"}],"container-title":["Revista Alergia M\u00e9xico"],"original-title":[],"link":[{"URL":"http:\/\/revistaalergia.mx\/ojs\/index.php\/ram\/article\/download\/984\/1484","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/revistaalergia.mx\/ojs\/index.php\/ram\/article\/download\/984\/1484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T13:10:38Z","timestamp":1676207438000},"score":1,"resource":{"primary":{"URL":"http:\/\/revistaalergia.mx\/ojs\/index.php\/ram\/article\/view\/984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":75,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,12,3]]}},"URL":"https:\/\/doi.org\/10.29262\/ram.v68i4.984","relation":{},"ISSN":["2448-9190","0002-5151"],"issn-type":[{"value":"2448-9190","type":"electronic"},{"value":"0002-5151","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,7]]}}}